Peter Gordon, MD, PhD

Peter Gordon

Pediatric Hematology/Oncology
425 East River Road
MCRB 554-C
Minneapolis, MN 55455
United States

Dr. Peter Gordon is an Assistant Professor of Pediatrics in the Division of Hematology/Oncology at the University of Minnesota. Dr. Gordon received his MD/Ph.D. from the University of Chicago in 2004. He completed his residency in Pediatrics in 2006 at Boston Children’s Hospital and his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplant in 2010 at Boston Children’s Hospital/Dana Farber Cancer Institute. After completing his fellowship, Dr. Gordon served as an Instructor in Pediatric Hematology/Oncology until 2014. During his fellowship and time as an instructor, he completed post-doctoral research fellowships in the laboratories of Dr. David Fisher (Massachusetts General Hospital) and Dr. David Williams (Children’s Hospital Boston) where his work focused on the role of the proto-oncogene c-KIT in cancer development.

 

Awards & Recognition

  • UMF Pediatric Scholar (2017-2018)
  • Minneapolis - St. Paul “Top Doctors, Rising Star Edition” (2015-2017)
  • Leukemia & Lymphoma Society (MN) Healthcare Provider Award (2016)
  • John & Carol Barry Foundation Award (2010)

Education

Assistant Professor, Department of Pediatrics

Faculty Member, Division of Pediatric Hematology and Oncology

 

Pediatric Hematologist/Oncologist

MD, University of Chicago, Chicago, IL

Residency in Pediatrics, Boston Children's Hospital, Boston, MA

Fellowship in Pediatric Hematology/Oncology, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA

Postdoctoral Fellowship in the Laboratory of Dr. David Fisher, Massachusetts General Hospital, Boston, MA

Postdoctoral fellowship in the Laboratory of Dr. David Williams, Children's Hospital Boston, Boston, MA

PhD, University of Chicago, Chicago, IL

Expand all

Research

Research Summary/Interests

Dr. Gordon’s laboratory interests focus on how an improved understanding of leukemia development and maintenance at the molecular and cellular level can be leveraged into better therapies. A particular area of interest includes investigating how soluble factors that are secreted by different cell types within the bone marrow and extra-medullary environments impact leukemia development and response to therapy. An additional interest is in using pediatric bone marrow failure syndromes, which often have a significantly increased risk for leukemia development, as model systems for investigating how cooperativity amongst oncogenes leads to leukemia development.

Clinical

Clinics

Journey Clinic - Center for Children with Cancer and Blood Disorders

Board Certifications

  • American Board of Pediatrics 
  • American Board of Pediatrics - Pediatric Hematology/Oncology